Business
Satellos to Participate in Upcoming Investor Conferences
TORONTO, February 17, 2026--Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) ("Satellos" or the "Company"), a clinical-stage biotechnology company focused on restoring natural muscle repair and regeneration in degenerative muscle diseases, today announced that management will present at and participate in the following investor conferences:
About this update from Satellos Bioscience Inc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1301,"height":302,"url":"https://media.zenfs.com/en/business-wire.com/10843e5c1af1cb0a011eddef50ac3f90"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UwDn9vf3wXj3CPSUveEhJA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTIyMztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/10843e5c1af1cb0a011eddef50ac3f90","width":960,"height":223},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/i9tUXKFsssHv0USVnNCQeA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD01NTg7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/10843e5c1af1cb0a011eddef50ac3f90","width":1200,"height":279}},"lazy":false},{"type":"text","content":"TORONTO, February 17, 2026--(BUSINESS WIRE)--Satellos Bioscience Inc. (Nasdaq: MSLE, TSX: MSCL) ("Satellos" or the "Company"), a clinical-stage biotechnology company focused on restoring natural muscle repair and regeneration in degenerative muscle diseases, today announced that management will present at and participate in the following investor conferences:","length":381,"tagName":"p"},{"type":"text","content":"Oppenheimer 36th Annual Healthcare Life Sciences ConferenceDate: Thursday, February 26, 2026Format: PresentationTime: 10:40 a.m. – 11:10 a.m. ETLocation: Virtual","length":165,"tagName":"p"},{"type":"text","content":"TD Cowen 46th Annual Health Care ConferenceDate: Tuesday, March 3, 2026Format: PresentationTime: 1:10 – 1:40 p.m. ETLocation: Boston, MA","length":140,"tagName":"p"},{"type":"text","content":"Leerink Partners Global Healthcare ConferenceDate: March 8-11, 2026Location: Miami, FL","length":88,"tagName":"p"},{"type":"text","content":"The presentations will be available via live webcast on the Events and Presentations page in the Investors section of the Company’s website.","length":140,"tagName":"p"},{"type":"text","content":"Members of the Satellos leadership team will also be available for one-on-one investor meetings during the conferences.","length":119,"tagName":"p"},{"type":"text","content":"ABOUT SAT-3247","length":14,"tagName":"p"},{"type":"text","content":"SAT-3247 is a proprietary, oral, small molecule drug candidate being developed by Satellos as a novel approach to regenerating skeletal muscle lost in Duchenne muscular dystrophy (DMD) and other dege...